Rollins (ROL) is back in focus after announcing that Executive Vice President and Chief Financial Officer Kenneth D. Krause will step down in mid June, with William W. Harkins set to take over.

Despite the CFO transition headlines, Rollins' share price has been under pressure recently. The stock is down 18.84% over 90 days and the 1 year total shareholder return is 12.10% lower, although the 5 year total shareholder return is 59.36%.

If this kind of corporate change has you rethinking your watchlist, it might be a good moment to widen your search and check out 21 top founder-led companies

With the stock under pressure, solid recent revenue and net income growth, and a value score of 1, the real question is whether Rollins is now trading below its fundamentals or if the market is already pricing in future growth.

Most Popular Narrative: 152% Overvalued

According to Esteban's narrative, Rollins' last close of $49.42 sits well above a fair value estimate of $19.63, which reflects a materially different view to the current market price.

Rollins is the dominant pure-play compounder in global pest control, a structurally necessary, recession-resistant service business that has grown revenue for 24 consecutive years and delivered ROIC of 23–31% for 12 consecutive years, without a single year of ROIC below 21% even through COVID-19. The investment thesis rests on three mutually reinforcing pillars: (1) a Wide Moat rooted in switching costs, commercial customers cannot switch providers without triggering compliance risk, and residential customers renew habitually at annual price increases of 3–4% above CPI without meaningful churn; (2) a proven M&A flywheel that converts a fragmented industry of 34,000+ U.S. operators into compounding route density and FCF, completing 30–45 bolt-on acquisitions annually at disciplined multiples with zero reported impairments; and (3) a capital-light business model with minimal reinvestment needs, generating FCF of $678M in FY2025 on $3.76B of revenue.

Curious how this narrative gets from a high quality, capital light compounder to such a low fair value. The answer lies in its long term growth, margin path, and the exit multiple tucked inside Esteban's model.

Result: Fair Value of $19.63 (OVERVALUED)

However, this story can break if acquisition returns weaken or if roll ups slow, and if margins or pricing power fall short of expectations.

Next Steps

Given the mixed tone so far, with strong fundamentals set against valuation and acquisition risks, take a moment to weigh the evidence for yourself. Then review the 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If Rollins has sharpened your thinking, do not stop here. Broaden your opportunity set now, or you risk missing stocks that may fit your goals better.

• Target potential value opportunities by scanning companies that screen well on quality and valuation using the 46 high quality undervalued stocks.
• Prioritise resilience by reviewing stocks that feature lower risk profiles through the 64 resilient stocks with low risk scores.
• Spot lesser known opportunities by checking a screener containing 22 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.